Skip to main content
. 2014 Oct 28;123(2):128–134. doi: 10.1289/ehp.1307839

Table 1.

Baseline demographic, clinical, and behavioral characteristics of study participants with and without incident CHD during follow-up (= 555).

Variable Total subcohort (n = 555)
Arsenic exposure TWA (μg/L-year)
1–20 428 (77)
20–30 86 (15)
30–45 33 (6)
45–88 8 (1)
Age (years, baseline) 57 (46–64)
Ethnicity
White non-Hispanic 296 (53)
Hispanic 259 (47)
Sex
Male 267 (46)
Female 288 (54)
Income
Low 304 (47)
High 251 (53)
First-degree family history of CHD
No 439 (81)
Yes 116 (19)
BMI (n = 1 missing) 26.0 (23.7, 29.4)
Diabetic (diagnosed at baseline visit)
No 546 (98)
Yes 9 (2)
Current smoker
Yes 262 (48)
No 293 (52)
Alcohol (g/week)
≤ 168 528 (95)
> 168 27 (5)
Water consumption (cups/day)
< 5 225 (39)
≥ 5 330 (61)
Physical activity
Sedentary 367 (69)
Active 188 (31)
Serum LDL (mg/dL) (n = 10 missing) 134 (108, 163)
Serum HDL (mg/dL) (n = 4 missing) 46 (38, 56)
Serum triglycerides (mg/dL) (n = 4 missing) 145 (102, 197)
Folate (mg) (dietary assessment estimate) 257 (183, 137)
Selenium (mg) (dietary assessment estimate) 98 (89, 48)
Values are n (%) or median (IQR).